Tounjian Advisory Partners’s Halozyme HALO Stock Holding History

Tounjian Advisory Partners’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02K	Buy	+13	New	+$886	﹤0.01%	662

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MMC

Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return

Tounjian Advisory Partners's HALO Position: Q2 2026 in Review

Tounjian Advisory Partners opened a new position in Halozyme (HALO) in Q2 2026: 13 shares worth $1.02K. The stake represents ﹤0.01% of the portfolio and ranks #662 among its holdings.

369 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Tounjian Advisory Partners held 13 shares of Halozyme worth $1.02K as of Q2 2026.
Halozyme was a new Tounjian Advisory Partners position in Q2 2026.
Halozyme made up ﹤0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #662 holding.
369 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.